Judit, Rhea Fe B.
HRN: 22-26-20 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
AMPICILLIN 1GM (VIAL)
03/19/2026
03/20/2026
IV
2gms
Q6hrs
PROM
Checking Initial Appropriateness
03/20/2026
CO-AMOXICLAV 625MG (TAB)
03/20/2026
03/26/2026
ORAL
625mg
BID X 7days
UTI
Checking Initial Appropriateness